Windlas Biotech balance sheet

As of Mar 2026

Total assets: ₹907cr+19.3% on Mar 2025
Shareholders' equity: ₹581cr+14.8% on Mar 2025
Total debt: ₹29.9cr+10.2% on Mar 2025
Cash and investments: ₹269cr+20.2% on Mar 2025

₹ crore except per share

Tap a line for its trend	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

Current assets
Non-current assets					FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	187	195	169	103
	56.2	3.2	5.7	13.8
	26.1	27.9	9.6	6.8
	3.4	2.1	0.0	1.0
	0.0	0.0	0.0	0.0
	6.3	4.3	4.3	7.6
	6.3	4.3	4.3	7.7
	0.4	0.3	0.6	2.0
	0.9	2.1	5.3	41.6
	280	235	195	175
	61.8	81.4	62.2	74.7
	268	223	173	107
	227	167	136	117
	0.5	0.4	5.2	3.7
	1.3	15.5	25.7	21.8
	9.6	1.0	1.5	1.5
	507	407	342	250
	57.8	33.3	26.2	28.5
	627	525	431	354
	907	760	626	529
Equity
	10.6	10.5	10.4	10.5
	570	495	440	392
	581	506	450	403
	581	506	450	403
Liabilities
	0.0	0.0	0.0	0.1
	2.2	2.4	2.2	0.3
	2.2	2.4	2.2	0.4
	3.3	2.9	2.3	2.0
	—	0.0	0.0	3.0
	5.6	5.2	4.5	5.5
	29.9	27.1	0.1	0.3
	238	167	131	87.4
	43.3	40.8	34.7	26.4
	312	235	166	114
	1.8	1.6	0.7	0.4
	2.3	0.0	0.0	0.6
	5.1	12.7	4.7	5.7
	321	249	171	121
	327	255	176	126
	907	760	626	529
Assets — additional as-filed lines
	0.0	3.3	0.7	0.0
Trade payables — MSME split
	26.3	12.0	—	—
	212	155	—	—

Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

alphave

WINDLAS₹888.70

Windlas Biotech Limited

· Pharma & Health

₹ CrorePeersHESTERBIO INDOCO SAIPARENT SYNCOMF PANACEABIO NGLFINE HIKAL JAGSNPHARMMcap ₹1,876 Cr

View

In ₹ Crore except Per Share As of	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Non-current Assets
+ Property, Plant & Equipment	102.6	169.5	195.5	187.2	187.2
+ Capital Work-in-Progress	13.8	5.7	3.2	56.2	56.2
+ Other Intangibles	6.8	9.6	27.9	26.1	26.1
+ Intangibles under Development	1.0	0.0	2.1	3.4	3.4
+ Non-current Investments	0.0	0.0	0.0	0.0	0.0
+ Other Non-current Financial Assets	7.6	4.3	4.3	6.3	6.3
Non-current Financial Assets	7.7	4.3	4.3	6.3	6.3
+ Deferred Tax Assets	2.0	0.6	0.3	0.4	0.4
+ Other Non-current Assets	41.6	5.3	2.1	0.9	0.9
Total Non-current Assets	175.5	194.9	235.3	280.5	280.5
Current Assets
+ Inventories	74.7	62.2	81.4	61.8	61.8
+ Current Investments	106.5	173.4	223.4	268.4	268.4
+ Trade Receivables	116.9	136.3	166.9	227.4	227.4
+ Cash & Cash Equivalents	3.7	5.2	0.4	0.5	0.5
+ Other Bank Balances	21.8	25.7	15.5	1.3	1.3
+ Other Current Financial Assets	1.5	1.5	1.0	9.6	9.6
Current Financial Assets	250.3	342.1	407.2	507.2	507.2
+ Other Current Assets	28.5	26.2	33.3	57.8	57.8
Total Current Assets	353.5	431.2	525.1	626.8	626.8
Total Assets	529.0	626.2	760.4	907.3	907.3
Equity
+ Equity Share Capital	10.5	10.4	10.5	10.6	10.6
+ Other Equity / Reserves	392.2	439.9	495.3	570.3	570.3
Equity — Owners of Parent	402.7	450.3	505.8	580.8	580.8
Total Equity	402.7	450.3	505.8	580.8	580.8
Liabilities
+ Borrowings — Non-current	0.1	0.0	0.0	0.0	0.0
+ Other Non-current Financial Liab	0.3	2.2	2.4	2.2	2.2
Non-current Financial Liabilities	0.4	2.2	2.4	2.2	2.2
+ Provisions — Non-current	2.0	2.3	2.9	3.3	3.3
+ Other Non-current Liabilities	3.0	0.0	0.0	—	—
Non-current Liabilities	5.5	4.5	5.2	5.6	5.6
+ Borrowings — Current	0.3	0.1	27.1	29.9	29.9
+ Trade Payables	87.4	131.1	167.2	238.5	238.5
+ Other Current Financial Liab	26.4	34.7	40.8	43.3	43.3
Current Financial Liabilities	114.2	166.0	235.1	311.7	311.7
+ Provisions — Current	0.4	0.7	1.6	1.8	1.8
+ Current Tax Liabilities	0.6	0.0	0.0	2.3	2.3
+ Other Current Liabilities	5.7	4.7	12.7	5.1	5.1
Current Liabilities	120.9	171.3	249.4	320.9	320.9
Total Liabilities	126.3	175.9	254.7	326.5	326.5
Total Equity & Liabilities	529.0	626.2	760.4	907.3	907.3
Assets — additional as-filed lines
+ Current Tax Assets	0.0	0.7	3.3	0.0	0.0
Trade Payables — MSME split
+ Dues to Micro & Small — Current	—	—	12.0	26.3	26.3
+ Dues to Other Creditors — Current	—	—	155.2	212.2	212.2

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · StandaloneFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.